The West Penn Allegheny Health System, rocked over the last 18 months by high-profile executive resignations and financial losses, said Monday that David R. Kiehn has been named chief financial officer, effective Jan. 5.
Kiehn serves as associate director of finance and operations at the Swedish Medical Center/Ballard Campus, in Seattle, where he's responsible for all areas of the hospital's finance, capital and operations budgeting, decision support, patient registration and accounting.
He's credited with implementing long-term financial planning to improve the hospital's profitability and has led a multimillion dollar financial turnaround at the institution, according to West Penn Allegheny.
"We are extremely pleased to have David Kiehn become part of our executive team," West Penn Allegheny Chief Administrative Officer Roy T. Santarella said in a statement. "His professional skills and financial acumen are well suited to the challenges and opportunities we face."
Prior to joining the Swedish Medical Center, Kiehn was vice president of financial operations at Stanford Hospital and Clinics, Palo Alto, Calif.; senior vice president of finance and technology at Evergreen Healthcare, Kirkland, Wash.; and chief financial officer at the University of Washington Medical Center, Seattle.
In the last 18 months, West Penn Allegheny Health System lost its president and CEO, Jerry Fedele, who was replaced less than one year ago by Christopher Olivia. Soon following Fedele out the door was Mark Palmer, president and CEO for barely eight months of the health care system's flagship The Western Pennsylvania Hospital.
In July, West Penn Allegheny disclosed that payments from patients and vendors had been overstated by $73 million, which led to an "informal inquiry" by the Securities and Exchange Commission, and a full fiscal year loss for the region's second-largest medical network of $62.8 million.
Earlier this month, West Penn Allegheny revealed it lost nearly $16 million during the three-month period ending Sept. 30.
No comments:
Post a Comment